These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7715479)

  • 1. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre.
    Cano A
    Maturitas; 1994 Dec; 20(2-3):91-9. PubMed ID: 7715479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1994 Dec; 20(2-3):81-9. PubMed ID: 7715478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance with hormone replacement therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy].
    Serfaty D; de Reilhac P; Eschwege E; Ringa V; Blin P; Nandeuil A; Tavera C; Mathieu M
    Gynecol Obstet Fertil; 2003 Jun; 31(6):525-33. PubMed ID: 12865191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogens following menopause. Methods of hormone replacement].
    Robyn C
    Rev Med Brux; 1995; 16(4):291-4. PubMed ID: 7481245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.
    Casper RF; Chapdelaine A
    Am J Obstet Gynecol; 1993 Apr; 168(4):1188-94; discussion 1194-6. PubMed ID: 8475965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M; Karakoç B; Gürler A
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy.
    Pearce J; Hawton K; Blake F
    Br J Psychiatry; 1995 Aug; 167(2):163-73. PubMed ID: 7582665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and hemostasis among postmenopausal women: a review.
    Canonico M
    Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual hormone replacement therapy.
    Tuimala RJ; Vihtamäki T
    Maturitas; 1996 May; 23 Suppl():S87-90. PubMed ID: 8865147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.